Many life-sciences companies are likely to execute an acquisition in the next 12-24 months, according to a survey by Ernst & Young.

The European Commission has asked certain pharmaceutical companies to submit copies of their patent-settlement agreements.

Zydus Cadila, a pharmaceutical company based in Ahmedabad, Gujarat, India, will begin conducting trials for a H1N1 vaccine.

On Jan. 4, 2010, Novartis (Basel) and Nestlé began completing their 2008 agreement, under which Novartis will acquire Nestlé's remaining 52% stake in eye-care company Alcon (Hünenberg, Switzerland).

The US Food and Drug Administration released a warning to the public on Dec. 29, 2009 about criminals posing as FDA special agents and other law enforcement personnel as part of an international extortion scam.

Bioject Medical Technologies establishes alliance with MPI Research; Biogen Idec CEO to retire; And More.

Microelectronics offers "striking opportunities" for advancing biomedical research and creating new markets for the medical sciences industry.

This study used biological indicators containing Geobacillus stearothermophilus spores and a new technology to continuously monitor incubated BIs and record nonsterile results.

A comprehensive book about mass transfer benefits from the author's personal touch.

From healthcare to corruption to life expectancy, here's what we can learn from the past decade.

Directors and staff miss the mark when it comes to following procedures.

BioNanomatrix (Philadelphia) names Edward Erickson president and CEO; and More.

Hospira, a specialty pharmaceutical company, has agreed to acquire Orchid Chemicals' Pharmaceuticals for $400 million.

Merck & Co. Acquires Avecia Biologics; Ambrilia Biopharma Closes Manufacturing Facility; And More.

Fraud and abuse in healthcare costs individual governments as much as $23 billion a year, according to estimates from the World Health Organization (WHO).

The European Public Health Alliance published its comments about the Falsified Medicines Directive currently under debate by the European Parliament and Council.

Mergers and acquisitions will contribute almost two-thirds of peer-set sales growth until 2014, according to market analyst Datamonitor.

Eli Lilly outlined its growth strategy at its annual meeting with the investment community last week.

Also, Abbott to acquire Starlims Technologies; GSK Biologicals to form alliance with Intercell.

PharmTech's monthly newsletter, Equipment & Processing Report, reviews the Editor's Picks for the December 2009 edition from Sepha and AdvantaPure.

Do advanced therapies represent medical miracles or risky business? This is the question that is debated by an Informa analyst in an Executive Briefing for Scrip.

The European Medicines Agency unveiled several changes to the organization, including a new structure and visual identity.

Company and People Notes: Also, Pfizer and Protalix enter agreement; Watson acquires Arrow Group; and more.

The US Congressional Budget Office released a report that analyzes the pharmaceutical industry?s advertising strategies.

Personalized medicine has been described by analysts PricewaterhouseCoopers as a "disruptive influence" that will create both opportunities and challenges for traditional healthcare.

The private industry has been urged to join a public sector commitment fund in the UK to advance manufacturing R&D in bioprocessing, following the investment of approximately £9 million from two UK research councils.

European business leaders are missing opportunities to reduce their environmental footprint and drive efficiencies through document governance, according to research from Ricoh, an electronic solutions provider.

sanofi-aventis (Paris) announced last week that it has signed a memorandum of understanding (MoU)with Prominvest.